We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Syri Ltd has been fined £51,000 and ordered to pay costs of £104,898 by Aylesbury Crown Court.
The MHRA has launched a public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Significant clarification of the life-changing EAMS scheme to be introduced into law.
This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19
National advertising campaign steps up today to encourage people to protect themselves and loved ones from COVID and flu this winter.
First published during the 2019 to 2022 Johnson Conservative government
Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by the Chief Pharmaceutical Officer for England.
The government has today published a consultation on aligning the upper age exemption for NHS prescription charges with the State Pension age (SPA).
Landmark collaboration to protect against future pandemic threats and slash time to develop and deploy new diagnostics, therapeutics and vaccines to 100 days.
The public has until 3 June to respond to the consultation on the potential reclassification of Nuromol to a general sale list medicine.
Balkeet Singh Khaira sold hundreds of thousands of Class C drugs from his mother's pharmacy
The public has until 5 March to respond to the consultation on the potential reclassification of desogestrel to a pharmacy medicine.
The new vaccine has been approved after meeting the required safety, quality and effectiveness standards.
The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years.
The MHRA has published advice for patients and healthcare professionals
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
The health minister's letter thanks directors of public health and their teams for their response to COVID-19 so far.
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
The health minister's letter thanks pharmacy teams for their response to coronavirus so far.
£300 million in funding will ensure community pharmacies can continue to carry out essential services during the coronavirus (COVID-19) outbreak.
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).